| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |